Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation.

Saved in:
Bibliographic Details
Title: Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation.
Authors: Kricker JA; EpiEndo Pharmaceuticals Ehf., Bjargargata 1, 102, Reykjavik, Iceland. Electronic address: jk@epiendo.com., Norris V; EpiEndo Pharmaceuticals Ehf., Bjargargata 1, 102, Reykjavik, Iceland., Page C; Institute of Pharmaceutical Science, King's College London, London, UK., Parnham MJ; EpiEndo Pharmaceuticals Ehf., Bjargargata 1, 102, Reykjavik, Iceland.
Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2025 Sep; Vol. 90, pp. 102364. Date of Electronic Publication: 2025 Jun 03.
Publication Type: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-9629 (Electronic) Linking ISSN: 10945539 NLM ISO Abbreviation: Pulm Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1522-9629
DOI:10.1016/j.pupt.2025.102364